Lexicon Pharmaceuticals Inc logo

Lexicon Pharmaceuticals Inc

1
NAS:LXRX (USA)   Ordinary Shares
$ 2.40 +0.21 (+9.59%) 04:00 PM EST
At Loss
P/B:
6.32
Market Cap:
$ 590.97M
Enterprise V:
$ 477.76M
Volume:
7.06M
Avg Vol (2M):
5.39M
Also Trade In:
Volume:
7.06M
At Loss
Avg Vol (2M):
5.39M

Business Description

Lexicon Pharmaceuticals Inc logo
Lexicon Pharmaceuticals Inc
NAICS : 325414 SIC : 2836
ISIN : US5288723027

Share Class Description:

LXRX: Ordinary Shares
Description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt 1.6
Equity-to-Asset 0.41
Debt-to-Equity 1.14
Debt-to-EBITDA -0.65
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10
Distress
Grey
Safe
Beneish M-Score 6.87
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.22
9-Day RSI 43.35
14-Day RSI 45.63
6-1 Month Momentum % 116.53
12-1 Month Momentum % 13.42

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.6
Quick Ratio 5.58
Cash Ratio 5.39
Days Inventory 1272.49
Days Sales Outstanding 139.46
Days Payable 49495.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.1
Shareholder Yield % -36.59

Financials (Next Earnings Date:2024-05-02 Est.)

LXRX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LXRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Lexicon Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.205
EPS (TTM) ($) -0.8
Beta 0.92
Volatility % 92.88
14-Day RSI 45.63
14-Day ATR ($) 0.23916
20-Day SMA ($) 2.3595
12-1 Month Momentum % 13.42
52-Week Range ($) 0.92 - 3.789
Shares Outstanding (Mil) 246.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lexicon Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Lexicon Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Lexicon Pharmaceuticals Inc Frequently Asked Questions

What is Lexicon Pharmaceuticals Inc(LXRX)'s stock price today?
The current price of LXRX is $2.40. The 52 week high of LXRX is $3.79 and 52 week low is $0.92.
When is next earnings date of Lexicon Pharmaceuticals Inc(LXRX)?
The next earnings date of Lexicon Pharmaceuticals Inc(LXRX) is 2024-05-02 Est..
Does Lexicon Pharmaceuticals Inc(LXRX) pay dividends? If so, how much?
Lexicon Pharmaceuticals Inc(LXRX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1